Zimbabwe has rejected a proposed US health funding agreement worth $367 million over five years, citing concerns over data sovereignty and unequal benefit-sharing. The decision emerged after a leaked government memo from December indicated that President Emmerson Mnangagwa considered the arrangement “lopsided”. The deal would have supported key public health programmes, but Harare objected to conditions attached to the funding.
According to government spokesperson Nick Mangwana, the United States had requested access to Zimbabwe’s biological samples and health data for research and potential commercial use, without guaranteeing that Zimbabwe would benefit from any resulting vaccines, diagnostics or treatments. Officials argued that the country would effectively provide raw materials for scientific discovery without assured access to the end products in the event of a future health crisis. They emphasised that the rejection should not be interpreted as anti-American, and expressed willingness to continue discussions under terms that respect national sovereignty.
In response, US Ambassador to Zimbabwe Pamela Tremont stated that the US would begin winding down health assistance programmes in the country. The US embassy noted that more than $1.9 billion in health funding has been provided to Zimbabwe over the past two decades. The proposed agreement would have supported programmes targeting HIV/AIDS, tuberculosis, malaria, maternal and child health, and outbreak preparedness, including services for approximately 1.2 million people receiving HIV treatment through US-backed initiatives.
The dispute comes amid broader changes in US foreign aid policy under President Donald Trump, whose administration has reduced foreign assistance and shifted towards direct government-to-government agreements. Zimbabwean officials also raised concerns that the US withdrawal from the World Health Organization could undermine multilateral mechanisms such as pathogen access and benefit-sharing systems designed to ensure equitable distribution of medical innovations during global health emergencies.
Local medical professionals have urged continued dialogue. The Zimbabwe College of Public Health Physicians acknowledged the government’s concerns about data governance but stressed that much of the country’s HIV response relies heavily on external financing. The association suggested that technical safeguards and negotiated clarifications could potentially resolve outstanding issues, allowing critical health programmes to continue without interruption.
